Medicine

EMA Grants Bersiporocin Orphan Drug Designation

January 30, 2024 - By 

The agency recognized the medication as a significant advancement for the treatment of IPF.

Related Posts

FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk

February 19, 2025

Navigating Distrust: Pharma in the Age of Social Media

February 19, 2025

Pharmaceutical Executive: February 2025 Issue (PDF)

February 18, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *